Arcturus Therapeutics Holdings Inc. (ARCT) › Operating IncomeArcturus Therapeutics Holdings Inc. (ARCT) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$21.81M2019: -$25.51M2020: -$71.52M2021: -$202.85M2022: $12.18M2023: -$78.20M2024: -$95.67M2025: -$76.26M-$76.26M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$76.26M+20.3%2024-$95.67M-22.3%2023-$78.20M-742.2%2022$12.18M+106.0%2021-$202.85M-183.6%2020-$71.52M-180.3%2019-$25.51M-17.0%2018-$21.81M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share